These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7659880)

  • 1. [Digoxin is effective in th treatment of patients with heart failure and sinus rhythm].
    Lanas F; Standen D; Steinmann WC; Montecinos A; Stockins B
    Rev Med Chil; 1994 Oct; 122(10):1147-52. PubMed ID: 7659880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the effects of digoxin or enalapril in the treatment of heart failure due to mitral insufficiency].
    Lanas F; Garcés E; Eggers G; Montecinos A; Díaz M; Gamboa C; Stockins B
    Rev Med Chil; 1998 Mar; 126(3):251-7. PubMed ID: 9674293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
    Alicandri C; Fariello R; Boni E; Zaninelli A; Muiesan G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S77-82. PubMed ID: 2483444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of digoxin on the quality of life in patients with heart failure.
    Lader E; Egan D; Hunsberger S; Garg R; Czajkowski S; McSherry F
    J Card Fail; 2003 Feb; 9(1):4-12. PubMed ID: 12612867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
    Just H; Drexler H; Taylor SH; Siegrist J; Schulgen G; Schumacher M
    Herz; 1993 Dec; 18 Suppl 1():436-43. PubMed ID: 8125424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Better efficacy of K-strophanthidin versus digoxin in subjects with dilated cardiomyopathy and chronic heart insufficiency].
    Agostoni PG; Doria E; Berti M; Guazzi MD
    Cardiologia; 1992 May; 37(5):323-9. PubMed ID: 1423365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
    J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.
    Tisdale JE; Overholser BR; Sowinski KM; Wroblewski HA; Amankwa K; Borzak S; Kingery JR; Coram R; Zipes DP; Flockhart DA; Kovacs RJ
    Pharmacotherapy; 2008 Dec; 28(12):1461-70. PubMed ID: 19025427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure.
    McMahon WS; Holzgrefe HH; Walker JD; Mukherjee R; Arthur SR; Cavallo MJ; Child MJ; Spinale FG
    J Am Coll Cardiol; 1996 Aug; 28(2):495-505. PubMed ID: 8800131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Right ventricular function and effort tolerance in patients with chronic congestive heart insufficiency. A cross-over double-blind study].
    Montes Orbe PM; Ormaetxe JM; Martínez JD; Rodríguez E; Ruiz de Azúa E; Iriarte MM
    Rev Esp Cardiol; 1990 Mar; 43(3):137-41. PubMed ID: 2185526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure in outpatients: a randomized trial of digoxin versus placebo.
    Lee DC; Johnson RA; Bingham JB; Leahy M; Dinsmore RE; Goroll AH; Newell JB; Strauss HW; Haber E
    N Engl J Med; 1982 Mar; 306(12):699-705. PubMed ID: 7038483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of verapamil in elderly patients with left ventricular diastolic dysfunction as a cause of congestive heart failure.
    Hung MJ; Cherng WJ; Kuo LT; Wang CH
    Int J Clin Pract; 2002; 56(1):57-62. PubMed ID: 11831838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Captopril versus digoxin in the treatment of mild to moderately severe heart failure].
    Heck I; Müller HM; Esser H; Lüderitz B
    Dtsch Med Wochenschr; 1989 May; 114(18):695-9. PubMed ID: 2653765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F
    Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.